Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Contact |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Corporate
Social Responsibility

Contact

Sanofi

Sanofi House
44 on Grand Central Office Park
2 Bond Street
Grand Central Extension 1
Midrand 16

Tel: +27 (0)11 256 3700
Fax: +27 (0)11 847 5099

If your question is related to an emergency, please consult your doctor or emergency unit.

Medical Information and Pharmacovigilance


Content :

Relations with patient associations

Sanofi recognizes the importance of transparency as a means to build trust with stakeholders, including the public, and most importantly the patient as the ultimate recipient of care.

 

Transparency with patient associations is an intrinsic part of Sanofi’s Global Principles covering interactions with patient associations. As part of an ongoing commitment, we continue to update our approach towards enhancement of transparency, which incorporates voluntary approaches.

From 2010 onwards, when disclosing our activities with patient associations based in Europe, we have included the financial amounts associated with these activities, prior to this becoming a mandatory requirement. Furthermore, we have extended the geographic coverage of activities from 2011 onwards to include the following countries:  Australia, Brazil, Canada, Japan and the United States.

Our interactions with patient associations in 2012 may be viewed in one of two ways: by selecting a country or as a consolidated list

Updated June 24, 2013

Module :

SANOFI - A global integrated healthcare leader, focused on patients' needs

Sanofi South Africa - Corporate Presentation